Bionano Genomics, Inc. (BNGO)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$1.09
-0.46%
Mkt Cap $3.68M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$46.50
Range $1.00 – $175.00
Implied Upside
+4185.7%
Consensus $46.50 vs current $1.09